Product Details
1/UN
$ *.**
In Stock
$ *.**
Additional Information
| Product Name | FASENRA® 30MG PFS |
| Active Ingredient | Benralizumab |
| Drug Class | Monoclonal Antibody; Anti-IL-5 Receptor Alpha |
| Mechanism of Action | Binds to IL-5Ra on eosinophils, inducing apoptosis via antibody-dependent cell-mediated cytotoxicity |
| Strength | 30 mg/mL |
| Volume | 1 mL |
| Side Effects | Headache, pharyngitis, injection site reactions, hypersensitivity |
| Precautions | Monitor for hypersensitivity reactions; not for acute bronchospasm |
| Warning | Discontinue if anaphylaxis or severe allergic reactions occur |
| Drug Interactions | No known significant drug interactions reported |
| Storage | Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light |
| Packing | Prefilled single-dose syringe |
| Uses | Add-on maintenance treatment for severe eosinophilic asthma in patients aged 12 years and older |
Frequently Asked Questions (FAQs)
The cost of FASENRA 30MG PFS is $$0.00
FASENRA 30MG PFS is manufactured by ASTRAZENECA.
You can purchase FASENRA 30MG PFS on our website at https://supplies.pipelinemedical.com/product/detail/fasenra-30mg-ml-30-mg-syringes-1x1-ml-640856